HALO Insider Trading

Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,463,598.50

Halozyme Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Halozyme Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Halozyme Therapeutics Share Price & Price History

Current Price: $38.58
Price Change: Price Decrease of -0.24 (-0.62%)
As of 09/26/2022 03:46 PM ET

This chart shows the closing price history over time for HALO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Halozyme Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/8/2021Helen TorleyCEOSell50,000$39.82$1,991,000.00View SEC Filing Icon  
11/5/2021Connie MatsuiDirectorSell32,000$40.38$1,292,160.00View SEC Filing Icon  
10/4/2021Helen TorleyCEOSell50,000$40.09$2,004,500.00View SEC Filing Icon  
10/1/2021Michael J. LaBarreSVPSell29,450$39.93$1,175,938.50View SEC Filing Icon  
9/7/2021Helen TorleyCEOSell50,000$42.38$2,119,000.00587,160View SEC Filing Icon  
8/25/2021Jean-Pierre BizzariDirectorSell35,000$41.01$1,435,350.00View SEC Filing Icon  
8/10/2021Helen TorleyCEOSell50,000$41.11$2,055,500.00View SEC Filing Icon  
7/6/2021Helen TorleyCEOSell50,000$45.97$2,298,500.00587,160View SEC Filing Icon  
7/1/2021Michael J. LaBarreSVPSell40,315$45.70$1,842,395.50View SEC Filing Icon  
6/7/2021Helen TorleyCEOSell50,000$39.66$1,983,000.00587,160View SEC Filing Icon  
5/11/2021Helen TorleyCEOSell50,000$43.02$2,151,000.00587,160View SEC Filing Icon  
4/14/2021Kenneth J. KelleyDirectorSell5,000$45.00$225,000.00179,833View SEC Filing Icon  
4/5/2021Helen TorleyCEOSell50,000$42.55$2,127,500.00587,160View SEC Filing Icon  
4/1/2021Michael J. LaBarreSVPSell28,689$42.56$1,221,003.84
3/1/2021Helen TorleyCEOSell50,000$46.19$2,309,500.00587,160View SEC Filing Icon  
3/1/2021Kenneth J. KelleyDirectorSell5,000$45.34$226,700.00185,333View SEC Filing Icon  
3/1/2021Michael J. LaBarreSVPSell18,324$45.81$839,422.44129,330View SEC Filing Icon  
2/1/2021Helen TorleyCEOSell50,000$47.84$2,392,000.00520,522View SEC Filing Icon  
2/1/2021Kenneth J. KelleyDirectorSell5,000$48.12$240,600.00190,079View SEC Filing Icon  
1/4/2021Kenneth J. KelleyDirectorSell5,000$42.91$214,550.00195,123View SEC Filing Icon  
12/21/2020Michael J. LaBarreSVPSell12,000$42.58$510,960.00123,400View SEC Filing Icon  
12/7/2020Kenneth J. KelleyDirectorSell35,086$41.00$1,438,526.00199,833View SEC Filing Icon  
12/2/2020Kenneth J. KelleyDirectorSell31,792$41.00$1,303,472.00234,919View SEC Filing Icon  
11/27/2020Kenneth J. KelleyDirectorSell10,000$41.25$412,500.00276,711View SEC Filing Icon  
11/25/2020Helen TorleyCEOSell50,000$40.73$2,036,500.00530,522View SEC Filing Icon  
11/25/2020Jeffrey William HendersonDirectorSell24,498$40.08$981,879.8447,609View SEC Filing Icon  
11/20/2020Michael J. LaBarreSVPSell12,000$38.76$465,120.00142,689View SEC Filing Icon  
10/20/2020Michael J. LaBarreSVPSell12,000$30.43$365,160.00146,800View SEC Filing Icon  
9/21/2020Michael J. LaBarreSVPSell12,000$26.91$322,920.00158,800View SEC Filing Icon  
9/11/2020Connie MatsuiDirectorSell32,000$27.06$865,920.00216,753View SEC Filing Icon  
8/20/2020Michael J. LaBarreSVPSell12,000$28.30$339,600.00170,800View SEC Filing Icon  
8/13/2020James M. DalyDirectorSell34,337$29.12$999,893.4431,365View SEC Filing Icon  
7/20/2020Michael J. LaBarreSVPSell12,000$29.01$348,120.00182,800View SEC Filing Icon  
5/20/2020Michael J. LaBarreSVPSell21,387$23.80$509,010.60197,574View SEC Filing Icon  
3/19/2020Kenneth J. KelleyDirectorBuy52,629$14.23$748,910.67242,467View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

91.72% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HALO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Halozyme Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/16/2022Federated Hermes Inc.83,547$3.68M0.0%-3.0%0.061%Search for SEC Filing on Google Icon
9/12/2022Hussman Strategic Advisors Inc.9,300$0.41M0.1%N/A0.007%Search for SEC Filing on Google Icon
9/2/2022Cim Investment Management Inc.6,199$0.27M0.1%+21.4%0.004%Search for SEC Filing on Google Icon
8/30/2022Verition Fund Management LLC14,877$0.66M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/23/2022Captrust Financial Advisors3,902$0.17M0.0%+15.6%0.003%Search for SEC Filing on Google Icon
8/22/2022Sheets Smith Investment Management12,066$0.51M0.6%N/A0.009%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc272,125$11.97M0.0%-6.7%0.198%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP160,279$7.05M0.1%+25.3%0.116%Search for SEC Filing on Google Icon
8/19/2022Walleye Capital LLC11,372$0.50M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/17/2022Advisory Research Inc.35,555$1.57M0.1%N/A0.026%Search for SEC Filing on Google Icon
8/16/2022First Republic Investment Management Inc.159,742$7.03M0.0%-22.8%0.116%Search for SEC Filing on Google Icon
8/16/2022Captrust Financial Advisors3,902$0.17M0.0%+15.6%0.003%Search for SEC Filing on Google Icon
8/16/2022Castleark Management LLC203,940$8.97M0.5%N/A0.148%Search for SEC Filing on Google Icon
8/16/2022United Services Automobile Association15,061$0.66M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/16/2022Colony Group LLC81,315$3.58M0.1%+0.6%0.059%Search for SEC Filing on Google Icon
8/16/2022Bank of Marin28,864$1.27M1.1%+14.0%0.021%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans1,326,058$58.35M0.2%-9.6%0.962%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD1,563,357$68.79M0.0%-0.1%1.135%Search for SEC Filing on Google Icon
8/16/2022Prudential Financial Inc.315,229$13.88M0.0%+269.6%0.229%Search for SEC Filing on Google Icon
8/16/2022Penn Capital Management Company LLC299,825$13.19M1.4%+33.3%0.218%Search for SEC Filing on Google Icon
8/16/2022Driehaus Capital Management LLC1,282,492$56.43M0.9%+51.9%0.931%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC54,200$2.39M0.0%-5.7%0.039%Search for SEC Filing on Google Icon
8/15/2022Macquarie Group Ltd.2,520,531$110.90M0.1%+1.9%1.829%Search for SEC Filing on Google Icon
8/15/2022Point72 Hong Kong Ltd3,553$0.16M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC202,355$8.90M0.1%+379.7%0.147%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC66,984$2.95M0.0%+5.9%0.049%Search for SEC Filing on Google Icon
8/15/2022Zebra Capital Management LLC6,877$0.30M0.9%+9.7%0.005%Search for SEC Filing on Google Icon
8/15/2022Voya Investment Management LLC109,552$4.82M0.0%-56.6%0.080%Search for SEC Filing on Google Icon
8/15/2022Quantamental Technologies LLC10,546$0.46M0.2%+31.6%0.008%Search for SEC Filing on Google Icon
8/15/2022Natixis Advisors L.P.37,840$1.67M0.0%+25.2%0.027%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.176,864$7.78M0.0%+5.6%0.128%Search for SEC Filing on Google Icon
8/13/2022Quantbot Technologies LP6,500$0.29M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/13/2022Rothschild & Co. Asset Management US Inc.183,771$8.09M0.1%-0.3%0.133%Search for SEC Filing on Google Icon
8/13/2022Teacher Retirement System of Texas21,920$0.96M0.0%-20.8%0.016%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC19,102$0.84M0.1%N/A0.014%Search for SEC Filing on Google Icon
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 16,734$0.74M0.0%-11.1%0.012%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC485,200$21.35M0.0%+133.6%0.352%Search for SEC Filing on Google Icon
8/13/2022Vanguard Personalized Indexing Management LLC5,582$0.25M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.289,997$12.76M0.1%-5.2%0.210%Search for SEC Filing on Google Icon
8/12/2022Natixis67,900$2.99M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp2,153,942$94.77M0.0%-4.0%1.561%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC5,324$0.23M0.1%-50.4%0.004%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc42,570$1.87M0.0%-7.7%0.031%Search for SEC Filing on Google Icon
8/12/2022First Light Asset Management LLC941,245$41.42M4.8%-41.1%0.682%Search for SEC Filing on Google Icon
8/12/2022LPL Financial LLC16,497$0.73M0.0%+14.1%0.012%Search for SEC Filing on Google Icon
8/12/2022Fox Run Management L.L.C.7,639$0.34M0.2%N/A0.006%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC87,152$3.84M0.0%-43.4%0.063%Search for SEC Filing on Google Icon
8/12/2022FMR LLC1,076,346$47.36M0.0%+19.4%0.781%Search for SEC Filing on Google Icon
8/12/2022Artisan Partners Limited Partnership6,365,361$280.08M0.5%-31.4%4.620%Search for SEC Filing on Google Icon
8/12/2022Kiwi Wealth Investments Limited Partnership18,707$0.82M0.1%N/A0.014%Search for SEC Filing on Google Icon
8/12/2022Corient Capital Partners LLC4,627$0.20M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/12/2022United Capital Financial Advisers LLC17,468$0.77M0.0%+93.8%0.013%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.688,216$30.28M0.0%+1,548.8%0.499%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers436,442$19.20M0.0%+5.0%0.316%Search for SEC Filing on Google Icon
8/11/2022AlphaCrest Capital Management LLC43,731$1.92M0.1%+74.8%0.032%Search for SEC Filing on Google Icon
8/11/2022Cetera Advisor Networks LLC5,522$0.24M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/11/2022O Shaughnessy Asset Management LLC10,947$0.48M0.0%+6.4%0.008%Search for SEC Filing on Google Icon
8/11/2022Axiom Investors LLC DE86,925$3.83M0.1%+34.7%0.063%Search for SEC Filing on Google Icon
8/11/2022EP Wealth Advisors LLC5,500$0.24M0.0%-35.3%0.004%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG78,872$3.47M0.0%-13.2%0.057%Search for SEC Filing on Google Icon
8/11/2022Martingale Asset Management L P5,220$0.23M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/11/2022Brown Brothers Harriman & Co.801$35K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/11/2022Harvest Fund Management Co. Ltd1,973$87K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/10/2022Synovus Financial Corp53,525$2.35M0.0%-31.0%0.039%Search for SEC Filing on Google Icon
8/10/2022Kennedy Capital Management Inc.602,011$26.49M0.7%+7.1%0.436%Search for SEC Filing on Google Icon
8/10/2022Mutual of America Capital Management LLC204,745$9.01M0.1%+59.5%0.148%Search for SEC Filing on Google Icon
8/10/2022Mackenzie Financial Corp62,256$2.74M0.0%-19.0%0.045%Search for SEC Filing on Google Icon
8/10/2022MGO One Seven LLC7,741$0.34M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/10/2022Nwam LLC4,950$0.23M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/10/2022Eagle Asset Management Inc.1,394,737$61.37M0.4%+16.4%1.011%Search for SEC Filing on Google Icon
8/10/2022California Public Employees Retirement System264,136$11.62M0.0%-7.6%0.191%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.634,560$27.92M0.0%+29.4%0.460%Search for SEC Filing on Google Icon
8/10/2022William Blair Investment Management LLC4,566,871$200.94M0.7%-14.5%3.311%Search for SEC Filing on Google Icon
8/10/2022Cerity Partners LLC5,953$0.26M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/10/2022Corbett Road Capital Management LLC16,525$0.73M1.2%N/A0.012%Search for SEC Filing on Google Icon
8/10/2022Inspire Investing LLC4,741$0.21M0.0%-19.9%0.003%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank324,400$14.27M0.0%+2.6%0.235%Search for SEC Filing on Google Icon
8/9/2022Pictet Asset Management SA121,867$5.36M0.0%-46.6%0.088%Search for SEC Filing on Google Icon
8/9/2022Lazard Asset Management LLC6,003$0.26M0.0%+3,010.4%0.004%Search for SEC Filing on Google Icon
8/9/2022Shell Asset Management Co.11,460$0.50M0.0%+42.6%0.008%Search for SEC Filing on Google Icon
8/8/2022AdvisorShares Investments LLC19,472$0.86M0.2%N/A0.014%Search for SEC Filing on Google Icon
8/8/2022Advisors Asset Management Inc.34,770$1.53M0.0%+26.7%0.025%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC11,372$0.50M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/8/2022Baird Financial Group Inc.70,688$3.11M0.0%+5.5%0.051%Search for SEC Filing on Google Icon
8/8/2022Oppenheimer & Co. Inc.7,544$0.33M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/8/2022TownSquare Capital LLC10,458$0.46M0.0%-12.3%0.008%Search for SEC Filing on Google Icon
8/8/2022Bay Colony Advisory Group Inc d b a Bay Colony Advisors4,450$0.22M0.1%N/A0.003%Search for SEC Filing on Google Icon
8/8/2022Texas Permanent School Fund100,039$4.40M0.1%+0.2%0.073%Search for SEC Filing on Google Icon
8/8/2022Verdence Capital Advisors LLC15,528$0.68M0.1%+10.7%0.011%Search for SEC Filing on Google Icon
8/8/2022State of Michigan Retirement System35,038$1.54M0.0%-2.0%0.025%Search for SEC Filing on Google Icon
8/8/2022Meeder Asset Management Inc.741$33K0.0%+223.6%0.001%Search for SEC Filing on Google Icon
8/8/2022Keybank National Association OH5,333$0.24M0.0%-22.9%0.004%Search for SEC Filing on Google Icon
8/8/2022Hancock Whitney Corp9,211$0.41M0.0%-6.8%0.007%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System51,100$2.25M0.0%-4.6%0.037%Search for SEC Filing on Google Icon
8/5/2022M&T Bank Corp102,326$4.50M0.0%+100.0%0.074%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.37,513$1.65M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/5/2022Ifrah Financial Services Inc.7,048$0.31M0.1%N/A0.005%Search for SEC Filing on Google Icon
8/5/2022Loomis Sayles & Co. L P2,172,478$95.59M0.2%-0.6%1.575%Search for SEC Filing on Google Icon
8/5/2022Los Angeles Capital Management LLC195,613$8.61M0.0%+0.9%0.142%Search for SEC Filing on Google Icon
8/4/2022Steward Partners Investment Advisory LLC1,300$57K0.0%N/A0.001%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Halozyme Therapeutics logo
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Read More on Halozyme Therapeutics

Today's Range

Now: $38.58
Low: $38.27
High: $39.03

50 Day Range

MA: $43.75
Low: $38.53
High: $51.70

52 Week Range

Now: $38.58
Low: $31.36
High: $52.98

Volume

22,600 shs

Average Volume

1,130,159 shs

Market Capitalization

$5.32 billion

P/E Ratio

15.25

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Halozyme Therapeutics?

Halozyme Therapeutics' top insider shareholders include:
  1. Helen Torley (CEO)
  2. Kenneth J Kelley (Director)
  3. Michael J Labarre (SVP)
  4. Jeffrey William Henderson (Director)
  5. Connie Matsui (Director)
  6. Jean-Pierre Bizzari (Director)
Learn More about top insider investors at Halozyme Therapeutics.

Who are the major institutional investors of Halozyme Therapeutics?

Halozyme Therapeutics' top institutional investors include:
  1. Artisan Partners Limited Partnership — 4.62%
  2. William Blair Investment Management LLC — 3.31%
  3. Macquarie Group Ltd. — 1.83%
  4. Loomis Sayles & Co. L P — 1.57%
  5. Northern Trust Corp — 1.56%
  6. Victory Capital Management Inc. — 1.30%
Learn More about top institutional investors of Halozyme Therapeutics stock.

Which major investors are selling Halozyme Therapeutics stock?

Within the last quarter, HALO stock was sold by these institutional investors:
  1. Artisan Partners Limited Partnership
  2. William Blair Investment Management LLC
  3. First Light Asset Management LLC
  4. Voya Investment Management LLC
  5. Thrivent Financial for Lutherans
  6. Candriam S.C.A.
  7. EFG Asset Management North America Corp.
  8. Pictet Asset Management SA
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
  1. Helen Torley (CEO)
  2. Kenneth J Kelley (Director)
  3. Michael J Labarre (SVP)
Learn More investors selling Halozyme Therapeutics stock.

Which major investors are buying Halozyme Therapeutics stock?

Within the last quarter, HALO stock was acquired by institutional investors including:
  1. Victory Capital Management Inc.
  2. Franklin Resources Inc.
  3. Driehaus Capital Management LLC
  4. Lisanti Capital Growth LLC
  5. Renaissance Technologies LLC
  6. Covington Capital Management
  7. Prudential Financial Inc.
  8. Castleark Management LLC